Chat with us
Research Assistance
Online
  • Please enter your first name.

South Africa Gastrointestinal Therapeutics Market, 2025-2033

The gastrointestinal therapeutics market in South Africa is expected to reach a projected revenue of US$ 480.2 million by 2033. A compound annual growth rate of 3.3% is expected of South Africa gastrointestinal therapeutics market from 2026 to 2033.

  • Pharmaceuticals
    • GI therapeutics
      • gastrointestinal therapeutics market
Revenue, 2025 (US$M)
$370.6
Forecast, 2033 (US$M)
$480.2
CAGR, 2026 - 2033
3.3%
Report Coverage
South Africa
South Africa Gastrointestinal Therapeutics Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Market

Related Markets

Prism AI by Grand View ResearchFree to try

Ask a question about the gastrointestinal therapeutics market

Every figure cited from GVR research

South Africa gastrointestinal therapeutics market highlights

  • The South Africa gastrointestinal therapeutics market generated a revenue of USD 370.6 million in 2025 and is expected to reach USD 480.2 million by 2033.
  • The South Africa market is expected to grow at a CAGR of 3.3% from 2026 to 2033.
  • In terms of segment, branded was the largest revenue generating drug type in 2025.
  • Generics is the most lucrative drug type segment registering the fastest growth during the forecast period.


Gastrointestinal therapeutics market data book summary

Market revenue in 2025USD 370.6 million
Market revenue in 2033USD 480.2 million
Growth rate3.3% (CAGR from 2026 to 2033)
Largest segmentBranded
Fastest growing segmentGenerics
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationBranded, Generics
Key market players worldwideAbbVie Inc, AstraZeneca PLC, Bausch Health Companies Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Abbott Laboratories, Janssen Pharmaceuticals, Sun Pharmaceutical Industries, Cipla Ltd DR, Gilead Sciences Inc, Biogen Inc, Organon & Co Ordinary Shares


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.9% of the global gastrointestinal therapeutics market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia gastrointestinal therapeutics market is projected to lead the regional market in terms of revenue in 2033.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 186.3 million by 2033.

The burden of gastrointestinal diseases in the African region has been high owing to easy transmission of bacterial and viral contaminants. Rising investment by major market players and increasing R&D are factors anticipated to fuel growth.

Rising number of government initiatives intended to extensively increase awareness among locals is expected to bolster growth in the region. For instance, the standard treatment guidelines and essential medicines list released by the Health Republic of South Africa.

The South African Gastroenterological Society—Academy of Digestive Diseases (SAGES-ADD) is another such organization facilitating training and improving diagnosis among locals for various gastrointestinal diseases.

No credit card required*

Publish Date: Mar 20, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gastrointestinal Therapeutics Market Companies

NameProfile# EmployeesHQWebsite
Abbott LaboratoriesView profile 114,000100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400www.abbottinvestor.com
AbbVie IncView profile 50,0001 North Waukegan Road, North Chicago, IL, United States, 60064-6400www.abbvieinvestor.com
Pfizer IncView profile 88,00066 Hudson Boulevard East, New York, NY, United States, 10001-2192www.pfizer.com
Cipla Ltd DRView profile 38,955Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013www.cipla.com
Bayer AGView profile 99,723Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368www.bayer.com
Sun Pharmaceutical IndustriesView profile 10001+Mumbai, Maharashtra, India, Asiawww.sunpharma.com
AstraZeneca PLCView profile 89,9001 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AAwww.astrazeneca.com
Gilead Sciences IncView profile 18,000333 Lakeside Drive, Foster, CA, United States, 94404www.gilead.com
Biogen IncView profile 7,570225 Binney Street, Cambridge, MA, United States, 02142www.biogen.com
Takeda Pharmaceutical Co LtdView profile 49,0951-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668www.takeda.com

South Africa gastrointestinal therapeutics market

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Gastrointestinal Therapeutics Market will help companies and investors design strategic landscapes.


Branded was the largest segment with a revenue share of 60.5% in 2025.

Horizon Databook has segmented the South Africa gastrointestinal therapeutics market based on branded, generics covering the revenue growth of each sub-segment from 2021 to 2033.




The burden of gastrointestinal diseases in the African region has been high owing to easy transmission of bacterial and viral contaminants. Rising investment by major market players and increasing R&D are factors anticipated to fuel growth.

Rising number of government initiatives intended to extensively increase awareness among locals is expected to bolster growth in the region. For instance, the standard treatment guidelines and essential medicines list released by the Health Republic of South Africa.

The South African Gastroenterological Society—Academy of Digestive Diseases (SAGES-ADD) is another such organization facilitating training and improving diagnosis among locals for various gastrointestinal diseases.

  • South Africa Gastrointestinal Therapeutics Market Drug Type Outlook (Revenue, USD Million , 2021-2033)
    • Branded
    • Generics
  • South Africa Gastrointestinal Therapeutics Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
    • Aminosalicylates
    • Digestive Enzymes
    • Proton Pump Inhibitors
    • Laxatives
    • Anti-emetics
    • H2 Antagonists
    • Anti-diarrheals
    • Biologics/Biosimilar
    • Other Drug Classes
  • South Africa Gastrointestinal Therapeutics Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
    • Oral
    • Injectables
    • Others Route of Administrations
  • South Africa Gastrointestinal Therapeutics Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Crohn's disease
    • Ulcerative colitis
    • GERD
    • IBS
    • Others Applications
  • South Africa Gastrointestinal Therapeutics Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Reasons to subscribe to gastrointestinal therapeutics market databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of gastrointestinal therapeutics market databook

  • Our clientele includes a mix of gastrointestinal therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa gastrointestinal therapeutics market, including forecasts for subscribers. This country databook contains high-level insights into South Africa gastrointestinal therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

South Africa Gastrointestinal Therapeutics Market, 2021-2033 (US$M)

No Access Stack Chart

South Africa gastrointestinal therapeutics market statistics, by drug type, 2021-2033 (US$M)

No Access Pie Chart

South Africa gastrointestinal therapeutics market statistics, by drug type, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more